I'd rather be on a tropical island.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi, do you think our common shares of NIOBF will uplist to NASDAQ with this round of reverse merger(s)? I do not see any mention of a symbol change for common shares post merger. Thank you for any insight.
Happy 2019 Traders!!!! What's new & exciting?
(crickets..........lol)
What is the deal with this thing?
BLRX, looking strong
CRON, still looking good
TRXC, FDA news coming
Squatch is in the house!!!
PTI, I'm diggin my 4.61 and 4.82 fills on this one.
Still in an uptrend, slow but steady. Needs news...
If thats true, what are they saying?
Someone bought 1 share for $5.17 after hours today. What is the point of that? lol
Any thoughts on why so low today?
TWLO looking good
Hey Feddy, what's new and exciting here?
Cheers,
Sid
MU, TWLO, CSCO, FEYE, GERN, AMD
Woot woot, gotta love it!
Hi Doog! You like this one? How have ya been?
Cheers, Sidney
IVITF watching it
Hi Augusta, its been quite a while, how are you? I just realized we are following some of the same stocks. Hope we both make money on them!
Cheers, Sidney
AXU
PVA
SFY
Great day here today!
Nice move today!
Time will tell
DCTH
Hey Folks!
Check out DCTH (Delcath Systems, Inc.)Today's range: $1.38 to $1.92
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. The Company's principal focus is on the treatment of primary and metastatic liver cancers. The Company’s product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. In the United States, Melphalan/HDS is considered a combination drug and device product, and is regulated as a drug by the United States Food and Drug Administration (FDA). In Europe, the Company’s system to deliver and filter melphalan hydrochloride is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). It has authorization to affix a CE Mark for Generation Two CHEMOSAT. The right to affix the CE Mark allows the Company to market CHEMOSAT in Europe.
Greetings traders! What snew?
Thanks EZ! Got ya marked too!
Yo, that you?
Don't be mad at me MOMO, but ARIO isn't tradable online through Just2trade as of today. What's the story with that? Thank you kindly.
Hello out there! I hope everyone is enjoying their summer!
God Bless!
Sidney
Hi Ray! Things are good. Not a lot of trading. You?
Happy New Year H-Dawg! Following any interesting stocks these days?
How's it going Cici? Following any interesting stocks?
Happy New Year you sweet thing!!!
VEND on watch
MDDD on watch
What is everyone trading for the new year?